1. Rat hepatocytes whose phosphatidylinositol 4-phosphate (PIP) and phosphatidylinositol 4,5-bisphosphate (PIP2) had been labelled for 60 min with 32p were treated with glucagon for 10 min or phenylephrine for 2 min. 2. Glucagon caused a 20% increase in PIP but no change in PIP2 whereas phenylephrine caused a similar increase in PIP but a 15% decrease in PIP2. Addition of both hormones together for 10 min produced a 40% increase in PIP. 3. A crude liver mitochondrial fraction incubated with [32P]P1 and ADP incorporated label into PIP, PIP2 and phosphatidic acid. The PIP2 was shown to be in contaminating plasma membranes and PIP in both lysosomal and plasma-membrane contamination. 4. A minor but definitely mitochondrial phospholipid, more polar than PIP2, was shown to be labelled with 32p both in vitro and in hepatocytes. 5. The rate of32P incorporation into PIP was faster in mitochondrial/plasmamembrane preparations from rats treated with glucagon or if 3 /SM-Ca2+ and Ruthenium Red were present in the incubation buffer. 6. Loss of 32P from membranes labelled in vitro was shown to be accompanied by formation of inositol 1,4,5-trisphosphate (IP3) and inositol 1,4-bisphosphate, and was faster in preparations from glucagon-treated rats or in the presence of 3,M-Ca2 . It is concluded that glucagon stimulates both PIP2 phosphodiesterase and phosphatidylinositol kinase activities, as does the presence of 3 /SM-Ca2+. The resulting formation of IP3 may be responsible for the observed release of intracellular Ca2+ stores. 8. The roles of a guanine nucleotide regulatory protein and phosphorylation in mediating these effects are discussed.
INTRODUCTION
It is now well established that Ca2+-mobilizing hormones such as phenylephrine, vasopressin and angiotensin stimulate the breakdown of PIP2 in the plasma membrane of liver cells, and that the released IP3 is responsible for mobilization of Ca2+ from the endoplasmic reticulum (see Michell et al., 1981; Berridge, 1984; Exton, 1985; Williamson et al., 1985) . These responses are extremely rapid and can be detected within a few seconds ofhormone addition. Glucagon and exogenous cyclic AMP are also known to cause Ca2+ mobilization from the same intracellular stores, but the mechanism of this release is not established (Charest et al., 1983; Sistare et al., 1985; Poggioli et al., 1986) . Wakelam et al. (1986) have reported that concentrations of glucagon below 10 nm can increase IP3 by a cyclic AMP-independent mechanism, whereas higher concentrations of the hormone are ineffective. This confirms the observations made in other laboratories that no effects on either IP3 or its parent phospholipid are apparent after 30 s or 1 min of glucagon (> 10 nM) treatment (Creba et al., 1983; Charest et al., 1985; Poggioli et al., 1986) . Paradoxically it has been reported that glucagon treatment leads to a stimulation of Ca2+ uptake into a liver microsomal preparation by a cyclic AMP-dependent mechanism, and this would appear to work against a glucagon-induced release from this store (Taylor et al., 1979 (Taylor et al., , 1980 Andia-Waltenbaugh et al., 1980) . During work in our laboratory on the effects of hormone treatment of rats on liver mitochondrial metabolism (for reviews see Halestrap, 1981 Halestrap, , 1986 Halestrap et al., 1983 Halestrap et al., , 1985 we began to investigate possible changes in phospholipid composition of the mitochondrial membrane induced by hormones Halestrap et al., 1983; Armston & Halestrap, 1984) . In the course of these studies it became apparent that, when a normal liver mitochondrial preparation was incubated with respiratory substrate, ADP and [32P]P1, there was incorporation of 32p into endogenous phosphatidic acid, PIP and PIP2 . Furthermore, glucagon treatment of the rats from which the mitochondrial fraction was derived was shown to influence this labelling process and stimulate subsequent breakdown of PIP and PIP2. Early work on the metabolism of these phospholipids suggested that they might be located in the mitochondrial membranes themselves, but it was later shown that they were synthesized in contaminating plasma membranes (Galliard & Hawthorne, 1963; Galliard et al., 1965; Hajra et al., 1965) . In the present paper we confirm that it is the contaminating plasma membranes of our crude liver mitochondrial preparation that incorporate 32p into PIP and PIP2 and that this preparation is suitable for studying the Vol. 241 Abbreviations used: PI, phosphatidylinositol; PIP, phosphatidylinositol 4-phosphate; PIP2, phosphatidylinositol 4,5-bisphosphate; IP2,myo-inositol 4,5-bisphosphate; IP,, myo-inositol 1,4,5-trisphosphate. metabolism of these phospholipids in vitro. We confirm that plasma membranes derived from glucagon-treated rats are able to hydrolyse PIP and PIP2 faster than those from control rats, and provide evidence that this also occurs in situ when hepatocytes are treated with glucagon. In addition we present data from experiments with isolated liver cells and plasma-membrane preparations that suggest that both Ca2+ and glucagon may cause a stimulation of PI kinase.
EXPERIMENTAL

Materials
[1-14C]Arachidonic acid was from Amersham International, Amersham, Bucks., U.K., and was stored in 5 ,uCi batches under N2. Neomycin sulphate was from Sigma, Poole, Dorset, U.K. All other chemicals, biochemicals and radiochemicals were from the sources cited previously .
Liver cells were isolated from male Wistar rats (250-300 g body wt.) starved for 24 h before use, and liver mitochondria from fed female Wistar rats (225-260 g body wt.), by standard methods described previously (Halestrap, 1978; Quinlan et al., 1983) . Where required, rats were first injected (intraperitoneally) with glucagon (1 mg/kg body wt.) 15 min before death (Halestrap, 1978) . Liver-cell incubations For the labelling of the phospholipids with 32p, liver cells were incubated at 10 mg of protein/ml in low-phosphate (0.575 mM) bicarbonate-buffered saline medium (Krebs & Henseleit, 1932) gassed with 02/CO2 (19:1) and containing [32P]P1 (0.1 mCi/ml), bovine serum albumin (20 mg/ml), 10 mM-L-lactate and 1 mM-pyruvate as described previously Quinlan et al., 1983) . After preincubation for 1 h, at which time it was confirmed that the labelling of the 4-and 5-phosphate groups of PIP and PIP2 had reached equilibrium (see also Creba et al., 1983; Thomas et al., 1983) , 100 nM-glucagon, 25 nM-vasopressin or 20 /zMphenylephrine was added as required. Incubation was continued for 10 min (glucagon) or 2 min (phenylephrine and vasopressin) before centrifugation of 1 ml samples of the cell suspension for 3 s in an Eppendorf 5414 centrifuge. The supernatant was then discarded and the pellet resuspended in either 1 ml of ice-cold extraction buffer (300 mM-sucrose, 20 mM-Tris/HCI, 2 mM-EGTA and 0.2 mM-neomycin sulphate) for the preparation of mitochondrial and plasma-membrane fractions (see below) or 250 #A of water for the measurement of whole-cell [32P]phospholipids. Where incorporation of [1-14C]arachidonic acid was to be studied, the protocol was identical except that [32P]P1 was replaced by 25 /M-[1-14C]arachidonic acid (1 ,uCi/ml) and preincubation was for 90 min . Fractionation of liver cells Liver cells were disrupted by sonication of the resuspended cell pellet as described previously (Vargas, 1982; Vargas et al., 1982; Quinlan et al., 1983) . Mitochondria were purified by density-gradient centrifugation by using Percoll and resuspended in 250 ,u ofwater for extraction of phospholipids. A plasma-membrane fraction was prepared by addition of Percoll (final concn. 17.5%, v/v) to the sonicated cell homogenate and centrifuging for 5 min at 10000 g and 5 'C. A 200,1 fraction was removed from the top of the Percoll gradient and mixed with 1 ml of sucrose extraction medium and centrifuged as before. The bottom 200,l of the resulting gradient was taken for the plasma-membrane fraction. 32P-labelling of plasma membrane phospholipids in vitro Time courses of the incorporation of 32p from [y-32P]ATP into the phospholipids of plasma membranes in crude mitochondrial preparations were performed at 37 'C in a medium containing 125 mM-KCl, 10 mM-Mops, 7 mM-Tris, 1 mM-EGTA, 0.25 mM-[32P]P, (0.1 mCi/ml). 5 mM-succinate, 0.1 mM-ADP and rotenone (1 jg/ml), adjusted to pH 7.25 with KOH. Buffer (2 ml) was incubated in sealed plastic vials (10 ml capacity) for 5 min at 37 'C in a shaking water bath before the crude mitochondrial preparation (8 mg of protein/ml) was added and rapidly vortex-mixed. At the required times 0.25 ml samples were removed and rapidly mixed with 0.6 ml ofchloroform/methanol/ 12 M-HCI (80: 40: 1, by vol.) containing 0.1 mg of 2,6-dibutylp-cresol/ml (Dawson & Eichberg, 1965 Results are given in Table 1 .
Vol. 241 Separation of diacylglycerols, inositol phospholipids and inositol phosphates Inositol-containing phospholipids were separated by t.l.c. on Merck 5735 silica-coated plastic sheets pretreated by wetting with acetone, soaking in potassium oxalate (1 %, w/v) for 5 min, activating at 110°C for 10 min and then developed in chloroform/acetone/methanol/acetic acid/water (40:15:13:12:8, by vol.) as described by Jolles et al. (1979) . For the separation of neutral lipids, oxalate treatment was omitted and the solvent system was benzene/diethyl ether/ethanol/ammonia (500:400:200:1, by vol.) as described by RittenhouseSimmons (1979) . Spots were detected by radioautography , and the radioactivity in each was determined. This was performed either by liquidscintillation counting after cutting out the relevant spot or by densitometric scan of the film with a Joyce-Loebl Chromoscan 3 interfaced to a Hewlett Packard 9845s computer. Known amounts of 32p were spotted before radioautography for standardization. When both techniques were performed on the same t.l.c. plate, the results agreed within 10% provided that the optical density of a spot on the radioautogram did not exceed 1. No attempt was made to quantify incorporation of label in absolute terms, but rather incorporation relative to control was estimated.
Inositol phosphates produced during incubation of the mitochondria/plasma membranes with [32P]P, were measured in the supernatant after precipitation of protein with 2% (w/v) HC104. After neutralization with 1 M-KOH containing 0.2 M-ethanolamine, a fraction containing the inositol phosphates was partially purified by formic acid/ammonium formate elution from Dowex 1 as described by . A 1 ml portion of neutralized extracts was applied to a 1.5 ml column of Dowex-1 (formate form), and the column was washed with 30 ml of0.1 M-formic acid/0.2 M-ammonium formate. The fraction eluted with 15 ml of 0.1 M-formic acid/i .0 M-ammonium formate was passed through a 50 ml column of Dowex 50W-X8 (acid form) and freeze-dried, before redissolution in water and separation of inositol phosphates by high-voltage electrophoresis by using a procedure modified from Agranoff et al. (1983) . Electrophoresis was for 20 min at 1000 V in 60 mM-oxalic acid (pH 1.8), on thin-layer cellulose plates (EastmanKodak). Samples of 32P-labelled 1P2 and IP3 were purified from erythrocytes as described by Downes et al. (1982) and used as standards. Spots were detected by radioautography as described above.
RESULTS
Effects of bormones on polyphosphoinositide metabolism by hepatocytes Table 2 presents data on the effects ofhormones on the 32p content of phosphatidic acid, PI, PIP and PIP2 of hepatocytes and a plasma-membrane fraction derived from them. The enrichment of this fraction with plasma membranes was only 2-3-fold, as shown in Table 1 . However, it could be produced with sufficient speed to minimize breakdown of PIP and PIP2; 200 ,sM-neomycin was also present throughout for this purpose. The statistical significance of the difference between control mitochondrial preparations and those prepared on the same day from glucagon-treated animals was determined by paired Student's t test: *P < 0.05; **P < 0.02; ***p < 0.01). Phospholipids in the mitochondrial/plasma-membrane fraction were either labelled with 32p in vitro for 10 min as described in the legend to Fig. 1 (part a, and part b, tracks 1-4), or in situ with isolated hepatocytes (part b, tracks 5-9) as described by Quinlan et al. (1983) . Treatment of the mitochondrial fraction with Percoll and digitonin was performed as described in the Experimental section before extraction of the phospholipids, separation by t.l.c. and radioautography. The location of phosphatidic acid (PA), phosphatidylethanolamine (PE), phosphatidylcholine (PC), PI, PIP and PIP2 were determined with standards. In addition, the location of an unidentified phospholipid (?), solvent front (F) and the origin (0) are marked.
of many others (see Exton, 1981; Creba et al., 1983; Thomas et al., 1983) , both phenylephrine and vasopressin produced a decrease in PIP2 and an increase in phosphatidic acid and PI labelling. Glucagon was without significant effect on any of these phospholipids.
However, in contrast with previous reports (Creba et al., 1983; Poggioli et al., 1986) , we also detected a significant increase in PIP in response to either glucagon or phenylephrine and an additive effect of both hormones together. In a separate set of experiments the incorporation of [14C]arachidonic acid into diacylglycerol was measured as described by Thomas et al. (1983) . The documented increased incorporation of label was observed with phenylephrine and vasopressin, but with glucagon the slight increase observed was not statistically significant. Time course of 32P incorporation into PIP and PIP2 of a mitochondrial/plasma-membrane fraction The time courses of 32P incorporation from [y-32P]ATP into phosphatidic acid, PIP and PIP2 in crude mitochondrial/plasma-membrane fractions prepared from control and glucagon-treated rats are shown in Fig.  l(a) . Results are given as the means+S.E.M. of ten separate experiments. As expected, the labelling of PIP precedes that of PIP2 and reaches a plateau at about 4 min, compared with the PIP2 which reaches a plateau at about 10 min. This is reflected in the steadily decreasing ratio of PIP to PIP2 at each successive time point (Fig. lb) . It was confirmed that the specific radioactivity of [y-32P]ATP, which is formed from [32P]P1 and ADP by the mitochondria in the assay, was maximal in less than 30 s. From the known rates of oxidative phosphorylation of the mitochondria, the labelling of the y-phosphate of ATP would reach equilibrium within 5 s or less. Several conclusions can be drawn from the data of Fig. 1 . The incorporation of 32P into PIP2 at equilibrium was less in the mitochondria from glucagontreated rats than in those from control animals, whereas that into phosphatidic acid was greater. There was no change in the equilibrium labelling of PIP. The ratio of PIP to PIP2 is the most sensitive indicator of changes in the metabolism of these two phospholipids since any variations in recovery and loading of the t.l.c. plate cancel out.-This ratio is shown in Fig. 1(b) to be significantly elevated in the mitochondrial/plasmamembrane preparation from glucagon-treated rats. At 15 min in 18 separate preparations, the increase in this ratio was 27.5+5.6% (P < 0.001 by paired Student's t test). There is also a small increase in labelling of PIP at 1 min. In 17 separate preparations from both control and glucagon-treated rats the incorporation of 32P at 1 min was 17.3 + 7.4% higher in the hormone-treated preparation (P < 0.05 by paired Student's t test).
In Fig. 2 (a) the effect of removing lysosomal and plasma-membrane contamination from the crude mitochondrial fraction on the labelling of PIP and PIP2 is shown. Removal of plasma membranes by Percolldensity-gradient centrifugation greatly decreased the amount of PIP2 concomitantly with the loss of most of the 5'-nucleotidase (Table 1) . Some PIP remained, but this was largely removed by digitonin treatment to destroy lysosomes, as shown by the loss of acid phosphatase (Table 1) . Lysosomes are known to possess a PI kinase but not a PIP kinase, which is consistent with these observations (Collins & Wells, 1983; Cockcroft et al., 1985) . Taken together, these results imply that the major incorporation Of 32p into the PIP and PIP2 observed in vitro in the crude mitochondrial fraction is into plasma membranes, as was concluded in earlier studies should be noted that a minor 32P-containing phospholipid running just below the PIP2 is consistently seen in the purified mitochondrial extract and, as shown in Fig.  2(b) , it is also present in the mitochondrial fraction purified from hepatocytes labelled with 32p. Before Percoll treatment this mitochondrial fraction (labelled in situ) also contained a considerable quantity ofPIP2 and is known to be contaminated with plasma membranes (Vargas, 1982) . However, after the Percoll treatment most of the PIP2 and plasma membranes were lost, but the novel phospholipid remained just as was apparent in the mitochondrial fraction labelled in vitro. The identity of this phospholipid is unknown, but it does appear to be truly mitochondrial rather than contamination by another membrane fraction.
In Fig. 3(a) . This concentration of Ca2+ slightly increased the rate of PIP synthesis, the incorporation at 1 min being greater by 22.8 + 9.5% (mean + S.E.M. of 15 separate experiments) in the incubations with Ca2+ (P < 0.05 by paired Student's t test). At later time points the 32P incorporation into PIP2 was significantly decreased, giving rise to an increase of 41.9+9.9% (n = 6; P < 0.01 by paired Student's t test) in the ratio of PIP to PIP2 at 15 min, as shown in Fig 3(b) . Labelling ofphosphatidic acid was significantly decreased in the presence of 3 /tM-Ca2+ at times less than 6 min, but this difference was lost at 15 min. We have no explanation for this observation. Loss of 32P from pre-labelled PIP and PIP2 of plasma pre-labelled with 32P for 6 min are shown in Fig. 4 . Mean data from three separate experiments with preparations from both control and glucagon-treated rats are shown, and in Table 3 combined data from 17 experiments are given for the breakdown of PIP and PIP2 at 20 min. Both PIP and PIP2 were lost during the incubation, and breakdown was significantly greater in the preparation from glucagon-treated rats. Table 3 also includes data demonstrating that 3 guM-Ca2+ stimulated and 250 tMneomycin inhibited breakdown. Loss of 32P could occur by either monoesterase or diesterase (phospholipase C) activity Irvine, 1982; Irvine et al., 1984) . The former enzyme would convert PIP2 into PIP and then PI. Thus a lag in the disappearance of PIP Vol. 241 would be be expected. This was not observed, as shown by the decrease in the ratio of PIP to PIP2 over the first 7 min (Fig. 4) . In some experiments the 32P-labelled PIP and PIP2 remaining after only 1 min incubation were measured, but were not found to be significantly different from the zero-time values. The ratio of PIP to PIP2 after 1 min incubation decreased by 7.6 + 4.0% (n = 6). These data are best explained by a phosphodiesterase activity being responsible for breakdown of PIP and PIP2. The inhibition of breakdown by 250,M-neomycin supports this conclusion . Such a phosphodiesterase would produce IP3 and IP2, which it should be possible to detect in the supernatant after deproteinizing samples from incubations in the 32P-labelling experiments. The usual method for measuring these water-soluble products involves incubating cells with [3H]inositol and separation of the [3H]inositol phosphates on ion exchange columns. The incorporation of 3H into peaks eluted at increasing ionic strength is used to calculate amounts of the individual inositol phosphates. However, [32P]P1 is incorporated into many different water-soluble components, some of which are inseparable from the inositol phosphates on ion-exchange columns. Thus, to measure 32P, incorporation into the inositol phophates, we were forced to use a combination of ion-exchange chromatography and electrophoresis. The HCI04 supernatant was neutralized and partially purified on Dowex 1 by using stepped elution with formic acid/ammonium formate before concentration by freezedrying and running on high-voltage electrophoresis at pH 1.8. Details are given in the Experimental section. Typical radioautograms of such electrophoretic separations are shown in Fig. 5 . Use of 32P-labelled standards prepared from human erythrocytes (Downes et al., 1982) confirmed the presence of IP3 and 1P2. There was evidence that both of these increased when 3,tsM-Ca2+ was present in the incubation and decreased in the presence of 250 /LM-neomycin (Fig. Sa) . In addition there was more IP3 present in the incubations of the membrane preparations from glucagon-treated animals (Fig. Sb) . However, we found it impossible to obtain quantitative data with these techniques, since the recovery of inositol phosphates from day to day was too variable, as seen by comparison of Figs. 5(a) and 5(b) . This may be explained partially by loss of the inositol phosphates during their isolation and separation, but is more likely due to a variable degree of hydrolysis in the incubation. In addition to the presence of radioactive spots corresponding to 1P3 and IP2 and those of ATP, pyrophosphate and phosphate, there was a major radioactive spot in the position where inositol monophosphate and other sugar phosphates such as glycerol 3-phosphate and glucose 6-phosphate were shown to run. It is possible that at least some of this is inositol 4-monophosphate, since it changes in parallel with 1P2 and IP3 and would be produced by the presence of 1P2 monoesterase in the incubation. This enzyme would be active at the concentration of Mg2+ required in these experiments to maintain mitochondrial stability (Storey et al., 1984; Joseph & Williams, 1985) and is likely to be present in variable activities from one preparation to another. Thus it could cause the variable recovery of 1P2 and IP3 observed. Nevertheless the qualitative changes in the inositol phosphates observed in response to glucagon treatment and Ca2+ complement the quantitative effects observed on the parent phospholipids.
DISCUSSION
Effects of glucagon treatment on polyphosphoinositide metabolism
The data presented in Table 2 show that glucagon can increase the amount of PIP in the plasma membrane of hepatocytes without affecting the amount of PIP2. These results contrast with those of Creba et al. (1983) and Poggioli et al. (1986) , who observed no effect of glucagon on PIP, but their studies used only a 1 min or 30 s exposure to glucagon, as opposed to 10 min used in the present studies. The effects that we observe could be caused by either an increase in PI kinase activity or an increase in the monoesterase that removes the 5-phosphate from PIP2. The slight but significant increase (17.3 + 7.4% ; n = 17) in the rate of incorporation of 32P into PIP in the liver mitochondrial preparation containing plasma membranes of glucagon-treated rats suggests that perhaps the kinase is activated. Effects of cyclic AMP on the synthesis of PIP have been described in the adrenal cortex, lymphocytes, platelets and granulocytes (Farese et al., 1980; Sarkadi et al., 1983; Enyedi et al., 1983; Farkas et al., 1984; de Chaffoy de Courcelles et al., 1986) , and the activity of PI kinase towards endogenous substrate is increased in extracts of adrenal cortex under conditions of increased cyclic AMP (Farese et al., 1980) . In addition to an effect of glucagon treatment on the PI kinase activity, the data of Fig. 3 and Table 3 show that this hormone also causes a stable increase in the phosphodiesterase activity responsible for cleaving PIP2 to IP3 and diacylglycerol. The former water-soluble product was detected by high-voltage electrophoresis, but appeared to be rapidly broken down by monoesterases present in the membrane fraction and contaminating cytoplasm (Storey et al., 1984; Joseph & Williams, 1985) . The diacylglycerol produced is probably the precursor of the phosphatidic acid that accumulates during the incubation. The time course of its production supports such a sequence of events. The increase in the formation of PIP might stimulate the synthesis of PIP2, but a concomitant increase in the breakdown of PIP2 could explain why the increase in the labelling of PIP seen in hepatocytes treated with glucagon is not accompanied by a change in PIP2. It could also explain the increase in the ratio of the labelling of PIP to PIP2 seen at equilibrium when the crude mitochondrial/plasma-membrane fraction from glucagon-treated rats is incubated with [32P]P1. A consequence of the stimulation of both enzyme activities would be an increase in the production of 1P3 and a subsequent release of intracellular Ca2+ from the endoplasmic reticulum. Such an increase in Ca2+ has been observed by using quin2 fluorescence (Charest et al., 1983; Sistare et al., 1985) and appears to be due to the release of Ca2+ from the same intracellular stores as those involved in the release of Ca2+ induced by agonists known to increase IP3 (Sistare et al., 1985; . However, no significant increase in 1P3 has been observed after treatment with glucagon at concentrations of 10 nm or greater Poggioli et al., 1986; Wakelam et al., 1986 ). This does not mean that a small increase in concentration does not occur, however, since such a small rise would be hard to detect . The effect of glucagon on cytoplasmic [Ca2+] is less than that caused by phenylephrine, and changes in the concentration of IP3 caused by this agonist are small Williamson et al., 1985) . There is some suggestion of an increase in IP3 at 100 nM-glucagon in the experiments of Wakelam et al. (1986) , but it is not significant.
The data presented in Table 2 show that, 10 min after addition, glucagon and phenylephrine have an additive effect on the increase in PIP. The combination of these two hormones is also known to have more than an additive effect on cellular Ca2+ metabolism (Morgan et al., 1983 (Morgan et al., , 1984 Mauger et al., 1985; McCormack, 1985b; ), but there is no evidence that this combination of hormones increases the production of IP3 in the hepatocyte within the first 1 min of their addition (Poggioli et al., 1986) . Rather, the available evidence suggests that the synergistic effect of the addition ofboth hormones is a consequence ofaltered Ca2+ flux across the plasma membrane (Mauger et al., 1985; Poggioli et al., 1986) .
The stability of the effect of glucagon treatment of animals that is observed in the crude plasma-membrane/ mitochondrial fraction suggests a covalent modification. The effects of glucagon on cytoplasmic [Ca2+] are only seen after a delay of a few seconds, and can also be elicited by addition of cyclic AMP or forskolin, suggesting the involvement of cyclic AMP-dependent protein kinase (Charest et al., 1983; Sistare et al., 1985) . In Fig 6 we show data obtained by using the endogenous NAD(P)H fluorescence to follow changes in cytoplasmic [Ca2+] . The validity of this approach has been argued in detail elsewhere and relies on the Ca2+ activation of the mitochondrial dehydrogenases in the liver (McCormack, 1985a) . On addition of concentrations of phenylephrine or vasopressin to give maximal fluorescence responses, there was no observable lag time in the rise in fluorescence, whereas with glucagon a lag time of 5.5 + 0.33 s (mean + S.E.M. of 14 observations on separate cell preparations) was detected. This agrees with the data obtained with quin2 by others (Charest et al., 1983; Sistare et al., 1985) . As is apparent in Fig. 6 and from the work of Thomas et al. (1984) , at submaximal concentrations of phenylephrine a lag time is barely detectable, whereas at submaximal concentrations of glucagon the lag time increases considerably. These results would be hard to reconcile with a direct interaction of a glucagon receptor with the phospholipase C responsible for the breakdown of PIP2. However, they would be compatible with a mechanism involving the cyclic AMP-dependent phosphorylation of some component involved in the activity of this enzyme, perhaps one of the GTP-binding proteins involved in hormone signal transduction.
Effects of Ca2+ on polyphosphoinositide metabolism
The data of Fig. 2 show that the presence of 3 /M-Ca2+ in the buffer used for labelling PIP and PIP2 in the crude mitochondria/plasma-membrane fraction caused an increased rate of PIP synthesis of a similar order to that seen in membranes from glucagon-treated animals. In these experiments the equilibrium concentration of PIP2 was decreased by the presence of Ca2+, and consequently the ratio of the two phospholipids was also changed in the same direction as with glucagon treatment. The decrease in PIP2 can be explained by the increase in its breakdown induced by Ca2+, as shown in Table 3 . Such an effect of Ca2+ on the phosphodiesterase activity is well established, although the exact sensitivity depends on many factors (Irvine et gt., 1984; Wallace & Fain, 1985; Melin et al., 1986; Uhing et al., 1986) . In Table 2 data were presented to show that phenylephrine, like glucagon, caused an increase in the concentration of PIP concomitant with a decrease in PIP2. Creba et al. (1983) and Poggioli et al. (1986) showed no change in the concentration of PIP 30 s or 1 min after addition of adrenaline, but a decrease in PIP2 similar to that observed here. Time courses of the effects of vasopressin and angiotensin show that the concentrations of both phospholipids fall rapidly in the first few seconds, and then PIP returns to control values over the next 5 min, whereas PIP2 concentrations are only partially restored (Creba et al., 1983; Thomas et al., 1983) . However, the concentrations of the inositol phosphates stay elevated throughopt this period (Thomas et al., 1984) . Taken together, these observations suggest that, coincident with an agonist-induced breakdown of PIP2, there is an increased synthesis. Release of a restraint on PI kinase imposed by PIP2 has been proposed as a mechanism for this effect (Van Rooijen et al., 1985) , but this would not account for the restoration of PIP preceding that of PIP2. There are also reports of protein kinase C-dependent stimulation of PI kinase activity in platelets (de Chaffoy de Courcelles et al., 1984; Halenda & Feinstein, 1984) , which might also occur in liver, although such a mechanism would oppose the down-regulation of the a.-adrenergic receptor induced by protein kinase C Vol. 241 phosphorylation of the receptor protein Lynch et al., 1985; Corvera et al., 1986) .
The data in the present paper would support an alternative mechanism for the stimulation of PIP formation seen after the initial agonist-mediated breakdown. Our studies in vitro with crude plasmamembrane/mitochondrial preparations exhibited PIP2 phosphodiesterase activity that was enhanced by the presence of micromolar [Ca2+] and by glucagon treatment of the rats from which they were derived. Both procedures also enhanced the synthesis of PIP in the incubations in vitro. Thus it is possible that the activity of the phosphodiesterase is in some way functionally related to that of the PI kinase. For glucagon treatment it is suggested that cyclic AMP-dependent phosphorylation of the guanine nucleotide regulatory protein linking the receptors to the phosphodiesterase may activate both processes. The effect of Ca2+ may not be physiological, but rather may mimic the activity of an agonist which activates the phosphodiesterase through the mediation of the GTP-binding protein. Such a mechanism would account for the observed sensitization of the aladrenergic receptor towards its agonists by glucagon and cyclic AMP (Morgan et al., 1984) . It is also compatible with the observed additive effect of glucagon and phenylephrine on PIP production (Table 1) .
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